Beauty Health (NASDAQ:SKIN – Get Rating) had its target price lowered by investment analysts at The Goldman Sachs Group from $22.00 to $19.00 in a research note issued on Wednesday, Marketbeat Ratings reports. The brokerage presently has a “buy” rating on the stock. The Goldman Sachs Group’s price objective points to a potential upside of 88.31% from the stock’s current price.
Several other analysts have also commented on SKIN. DA Davidson lifted their price objective on Beauty Health to $32.00 in a report on Tuesday, November 15th. Piper Sandler lifted their price objective on Beauty Health from $20.00 to $23.00 and gave the stock an “overweight” rating in a report on Friday, September 16th. Finally, JPMorgan Chase & Co. lowered Beauty Health from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $22.00 to $11.00 in a report on Wednesday, November 9th. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, Beauty Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $21.14.
Beauty Health Stock Performance
Shares of SKIN opened at $10.09 on Wednesday. The company has a debt-to-equity ratio of 2.84, a current ratio of 11.68 and a quick ratio of 10.34. Beauty Health has a one year low of $8.27 and a one year high of $28.65. The firm has a market capitalization of $1.44 billion, a P/E ratio of -30.58 and a beta of 1.07. The business has a fifty day moving average of $11.42 and a 200 day moving average of $12.28.
Institutional Trading of Beauty Health
Beauty Health Company Profile
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
- Get a free copy of the StockNews.com research report on Beauty Health (SKIN)
- Is the 60/40 Portfolio Mix Still in Vogue?
- Microsoft Shares: Is it Time to Back Up the Truck?
- Three CBD Stocks to Dominate a Budding Industry
- Institutional Support for Analog Devices Remains High
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.